About FDA
Cumulative percent of contracts awarded over the micro-purchase threshold which are competed within the month (1)
Dictionary: The Competition in Contracting Act of 1984, encourages competition for the award of all types of government contracts to increase the number of competitors and to increase the saving through lower, more competitive pricing. Further, President Obama has mandated that the Federal government save $40B a year in contracting and one way to achieve this savings is through competing contract actions.
The Department has mandated that at least 65% of all contract actions awarded over the micro-purchase threshold are competed.
Fiscal Year - 2010
| Time | Target | Percent |
|---|---|---|
| Oct – Dec 2009 | 65 | 86 |
| Jan – Mar 2010 | 65 | 87 |
| Apr – Jun 2010 | 65 | 90 |
| Jul – Sep 2010 | 65 | 91 |
FY 2010 Year-End: 91%
Footnotes
- (1) $3K and under is a micro purchase and is not subject to competition rules.
Cumulative number of contracts over the micro-purchase threshold competed within the month
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct – Dec 2009 | N/A | 309 |
| Jan – Mar 2010 | N/A | 623 |
| Apr – Jun 2010 | N/A | 1,446 |
| Jul – Sep 2010 | N/A | 3,204 |
FY 2010 Year-End Total: 3,204
Cumulative number of contracts over the micro-purchase threshold awarded within the month (2)
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct – Dec 2009 | N/A | 403 |
| Jan – Mar 2010 | N/A | 781 |
| Apr – Jun 2010 | N/A | 1,609 |
| Jul – Sep 2010 | N/A | 3,511 |
FY 2010 Year-End Total: 3,511
Footnotes
- (2) Amount (actions and dollars) also includes awards that aren’t available for competition for actions that are exempt by statute from competition.
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







